Immunoassays also find higher blood levels of phosphorylated α-synuclein in PD patients but levels in DLB patients, and the association with CSF α-synuclein RT-QuIC measurements, remain largely unknown and warrant future studies [75–77]. Here, SNCA is linked to Parkinson disease.